← Back to Patent Explorer
US4596805A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted dioxopyridopyrimidines

Assignee: Ortho Pharmaceutical Corp
•
Filing: 1984-06-13
•
Granted: 1986-06-24
•
Expires: 2004-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substituted dioxopyridopyrimidines are provided which are useful as calcium antagonists and anti-hypertensive agents.

Inventors

  • 👤 Jack B. Jiang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 13:57
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 67 words
A compound having the formula ##STR7## and the pharmaceutically acceptable acid addition salts thereof, wherein: R is hydrogen or loweralkyl; Ar is aryl, furanyl, or cyclohexyl; R' is loweralkyl, loweralkyl substituted with one halo or trifluoromethyl group, or (arylloweralkyl)(loweralkyl)aminoloweralkyl; and X is 0 or S; said aryl being phenyl or phenyl substituted with one or two substituents independently selected from halo, nitro, cyano, loweralkyl, loweralkyloxy, and trifluoromethyl.
Claim 2
Dependent Claim 67 words
A compound having the formula ##STR7## and the pharmaceutically acceptable acid addition salts thereof, wherein: R is hydrogen or loweralkyl; Ar is aryl, furanyl, or cyclohexyl; R' is loweralkyl, loweralkyl substituted with one halo or trifluoromethyl group, or (arylloweralkyl)(loweralkyl)aminoloweralkyl; and X is 0 or S; said aryl being phenyl or phenyl substituted with one or two substituents independently selected from halo, nitro, cyano, loweralkyl, loweralkyloxy, and trifluoromethyl.
Claim 3
Dependent Claim 25 words
The compound of claim 1 wherein R is lowerlkyl, X is O, Ar is aryl, and R' is loweralkyl, halo-substituted loweralkyl, or (arylloweralkyl) (loweralkyl) aminoloweralkyl.
Claim 4
Dependent Claim 23 words
The compound of claim 1 wherein R is methyl, X is O, Ar is aryl, and R' is halo-substituted loweralkyl or (arylloweralkyl)(loweralkyl) aminoloweralkyl.
Claim 5
Dependent Claim 39 words
The compound of claim 1 wherein R is methyl, X is O, Ar is 3-halophenyl or 3-nitrophenyl, and R' is CH 2 CH 2 Br or CH 2 CH 2 N(CH 3 )CH 2 --C 6 H 5 .
Claim 6
Dependent Claim 37 words
The compound of claim 1 wherein R is methyl, X is O, Ar is 3-chlorophenyl, and R' is CH 2 CH 2 Br or CH 2 CH 2 N(CH 3 )CH 2 --C 6 H 5 .
Claim 7
Dependent Claim 10 words
The compound of claim 1 which is 2-(N-benzyl-N-methylamino)ethyl 5-(3-chlorophenyl)-5,8-dihydro-1,3,7-trimethyl-2,4 dioxopyrido[2,3-d]pyrimidine-6-carboxylate.
Claim 8
Dependent Claim 21 words
A pharmaceutical composition comprising an effective anti-hypertensive amount of a compound of claim 1 in admixture with a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 23 words
A pharmaceutical composition comprising an effective calcium channel inhibiting amount of a compound of claim 1 in admixture with a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US2926166A Cited
DE2334266A1 Cited
DE2738153A1 Cited
US4304914A Cited
US4321384A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-06-23 1989-12-23 1990-06-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-06-23 1993-12-23 1994-06-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-06-23 1997-12-23 1998-06-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag